cagrilintide drug Retatrutide Blend Peptide 1 CagriSema 2.4 mg /
Description
The method of claim 7, wherein said one or more HGF mimics is administered in the form of a pharmaceutically acceptable salt
References: Schnyder G, et al
Ethn Dis 2005;15:418423
doi: 10.3390/ijms17060939 83 IzzoGFrancescoAFerraraDCampitielloMRSerinoIMinucciSet al
Khanizadeh F, Rahmani A, Asadollahi K, Ahmadi MRH
